Diabetes epidemic' in Germany? A critical look at health insurance data sources

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 7, 2012, Pages 410-415

  Hoffmann, F ^a   Icks, A ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

diabetes mellitus; health insurance claims data; international comparison; prevalence

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; COMORBIDITY; DATA ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; EPIDEMIC; FEMALE; GERMANY; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVIEW; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FALSE POSITIVE REACTIONS; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 84863783341     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1306331     Document Type: Review

References (29)

1. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Nationale VersorgungsLeitlinie Typ-2-Diabetes Präventions- und Behandlungsstrategien für Fußkomplikationen. Langfassung Version 2.8,: 2010; http://www.versorgungsleitlinien.de/themen/ diabetes2/dm2-fuss/pdf/nvl-t2dfuss-lang.pdf (Accessed: 18 June, 2011)
2. Ellert U, Wirz J, Ziese T. Telefonischer Gesundheitssurvey des Robert Koch- Instituts (2. Welle). Deskriptiver Ergebnisteil. Berlin Robert Koch-Institut,: 2006
3. Federal Ministry of Health Gesetzliche Krankenversicherung: Mitglieder, mitversicherte Angehörige, Beitragssätze und Krankenstand. Monatswerte Januar bis Juni 2004 (Ergebnisse der GKV-Statistik KM1),: 2004; http://www.bmg.bund.de/fileadmin/redaktion/pdf-statistiken/krankenversicherung/ KM1Monat-pdf-4865.pdf Accessed: 18 June, 2011. (Archived by WebCite® at http://www.webcitation.org/5xfvwMPXE)
4. Federal Ministry of Health Gesetzliche Krankenversicherung: Mitglieder, mitversicherte Angehörige und Krankenstand. Monatswerte Januar: 2011; (Ergebnisse der GKV-Statistik KM1), 2011. http://www.bmg.bund.de/fileadmin/ redaktion/pdf-statistiken/krankenversicherung/Mitglieder-Versicherte-GKV-Januar- 2011.pdf Accessed: 18 June, 20101 (Archived by WebCite® at http://www.webcitation.org/5xfw4s90q)
5. Geyer S, Peter R, Nielsen I. Health inequalities in different age groups: the case of type 2-diabetes: a study with health insurance and medication data. Soz Praventivmed: 2004; 49 328 335 (Pubitemid 39294929)
6. Hauner H, Köster I, Schubert I. Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus. Eine Analyse der Versichertenstichprobe AOK Hessen/KV Hessen im Zeitraum von 1998 bis 2004. Dtsch Ärztebl: 2007; 104 A2799 A2805 (Pubitemid 350032480)
7. Hauner H. Diabetesepidemie und Dunkelziffer. In diabetes ed. Deutscher Gesundheitsbericht Diabetes 2011. Mainz Kirchheim Verlag: 2011; 8 13
8. Heidemann C, Kroll L, Icks A et al. Prevalence of known diabetes in German adults aged 25-69 years: results from national health surveys over 15 years. Diabet Med: 2009; 26 655 658
9. Hoffmann F, Haastert B, Koch M et al. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant: 2011; 26 1634 1640
10. Hoffmann F, Icks A. Diabetes prevalence based on health insurance claims: large differences between companies. Diabet Med: 2011; a 28 919 923
11. Hoffmann F, Icks A. Unterschiede in der Versichertenstruktur von Krankenkassen und deren Auswirkungen für die Versorgungsforschung: Ergebnisse des Bertelsmann-Gesundheitsmonitors. Gesundheitswesen: 2011; b 2011 Jul 13 [Epub ahead of print]
12. Icks A, Haastert B, Trautner C et al. Incidence of lower-limb amputations in the diabetic compared to the non-diabetic population. findings from nationwide insurance data, Germany, 2005-2007. Exp Clin Endocrinol Diabetes: 2009; 117 500 504
13. Icks A, Scheer M, Morbach S et al. Time-Dependent Impact of Diabetes on Mortality in Patients After Major Lower Extremity Amputation: Survival in a population-based 5-year cohort in Germany. Diabetes Care: 2011; 34 1350 1354
14. International Diabetes Federation (IDF) Diabetes Atlas. 4th Edition Brussels International Diabetes Federation: 2009
15. Kohler M, Rieck A, Borch S et al. Erster telefonischer Gesundheitssurvey des Robert Koch-Instituts-Methodische Beiträge. Berlin Robert Koch-Institut: 2005
16. Köster I, Huppertz E, Hauner H et al. Direct Costs of Diabetes Mellitus in Germany - CoDiM 2000-2007. Exp Clin Endocrinol Diabetes: 2011; 119 377 385
17. Köster I, von Ferber L, Ihle P et al. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM study. Diabetologia: 2006; 49 1498 1504 (Pubitemid 43848085)
18. Linder R, Ahrens S, Köppel D et al. The benefit and efficiency of the disease management program for type 2 diabetes. Dtsch Arztebl Int: 2011; 108 155 162
19. Lisac M, Reimers L, Henke K D et al. Access and choice - competition under the roof of solidarity in German health care: an analysis of health policy reforms since 2004. Health Econ Policy Law: 2010; 5 31 52
20. Meisinger C, Heier M, Doering A et al. KORA Group. Prevalence of known diabetes and antidiabetic therapy between 1984/1985 and 1999/2001 in southern Germany. Diabetes Care: 2004; 27 2985 2987 (Pubitemid 39565073)
21. Miksch A, Laux G, Ose D et al. Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care: 2010; 16 49 54
22. OECD Diabetes Prevalence and Incidence. In: OECD Health at a Glance: Europe 2010. 2010; 52 53 10.1787/9789264090316-19-en
23. Robert Koch Institut Daten und Fakten: Ergebnisse der Studie Gesundheit in Deutschland aktuell 2009" Berlin Robert Koch Institut: 2011
24. Schipf S, Werner A, Tamayo T et al. Regional differences in the prevalence of known type 2 diabetes mellitus in 45-74 years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med: 2012; 10.1111/j.1464-5491.2012.03578.x. [Epub ahead of print]
25. Schulze M B, Rathmann W, Giani G et al. Diabetesprävalenz. Verlässliche Schätzungen stehen noch aus. Die von der International Diabetes Federation vorgelegten Daten sind nicht belastbar. Ein Plädoyer für bessere epidemiologische Daten. Dtsch Arztebl: 2010; 10 A1694 A1696
26. Stock S, Drabik A, Büscher G et al. German diabetes management programs improve quality of care and curb costs. Health Aff (Millwood): 2010; 29 2197 2205
27. Stock S A, Redaelli M, Wendland G et al. Diabetes - prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet Med: 2006; 23 299 305
28. von Elm E, Altman D G, Egger M et al. STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med: 2007; 4 10 e296
29. von Ferber L, Köster I, Hauner H. Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study. Exp Clin Endocrinol Diabetes: 2007; 115 97 104 (Pubitemid 46408116)